ProMIS Neurosciences, Inc.

PMN · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income$3-$13-$18-$9
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$1$0$0$0
Change in WC-$12$3$5-$2
Other Non-Cash-$19-$1-$5$1
Operating Cash Flow-$27-$11-$17-$9
Investing Activities
PP&E Inv.$0$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$0-$0-$0-$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$0-$0-$0$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$28$18$5$26
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$2$0
Financing Cash Flow$28$18$6$26
Forex Effect$0-$0-$1-$0
Net Chg. in Cash$1$7-$11$16
Supplemental Information
Beg. Cash$13$6$17$1
End Cash$13$13$6$17
Free Cash Flow-$27-$11-$17-$9
ProMIS Neurosciences, Inc. (PMN) Financial Statements & Key Stats | AlphaPilot